Last reviewed · How we verify
Valproic Acid and Depakote ER
Valproic Acid and Depakote ER, marketed by Joliet Center for Clinical Research, is a well-established treatment in its class. The key composition patent is set to expire in 2028, providing a significant period of market exclusivity. The primary risk lies in potential competition from generic entries post-patent expiry.
At a glance
| Generic name | Valproic Acid and Depakote ER |
|---|---|
| Sponsor | Joliet Center for Clinical Research |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma (PHASE2)
- A Study to Investigate Treatment of HU and VPA, or 6-MP and VPA in Unfit AML/HR-MDS Patients (PHASE1, PHASE2)
- Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)? (PHASE4)
- Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca (PHASE1, PHASE2)
- Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy (PHASE2)
- The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients (PHASE1, PHASE2)
- Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
- Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Valproic Acid and Depakote ER CI brief — competitive landscape report
- Valproic Acid and Depakote ER updates RSS · CI watch RSS
- Joliet Center for Clinical Research portfolio CI